OECD TG 414
OECD TG 414 is the standard ‘Prenatal Developmental Toxicity Study’, i.e. the Study on prenatal developmental toxicity, which is included in Section 4 (Health Effects) of the OECD Test Guidelines for the Testing of Chemicals. The test aims to, the effects of a test substance on embryo and foetal development in pregnant animals to assess. The study enables the joint investigation of maternal toxicity, embryo-foetal toxicity and teratogenic potential.
The basic principle of the test is to administer the test substance during the stage of pregnancy that encompasses organogenesis and to examine the foetuses towards the end of pregnancy by caesarean section.
Rats are generally used; depending on regulatory requirements, a second species, such as rabbits, may be preferred. The route of administration, dosages and duration of treatment are determined in accordance with the physicochemical properties of the test substance and the expected route of exposure.
The main parameters assessed in the study are as follows:
Maternal parameters:
Clinical observations, body weight and feed intake
- Pregnancy rate and uterine weight
- Indicators of maternal toxicity
Embryonic and foetal parameters:
- Number of corpus luteums, number of implantations
- Number of live, stillborn and resorbed foetuses
- Foetal body weight and sex ratio
- External examination: malformations and abnormalities
- Visceral examination: abnormalities of the internal organs
- Skeletal examination: bone malformations and abnormalities
The primary purpose of the test is to scientifically evaluate the relationship between maternal toxicity and embryo-foetal development, and to determine the developmental toxicity potential of the test substance.
The study design includes a negative control group, a solvent control group and, where appropriate, a positive control group; the dose levels and group sizes are justified in accordance with the regulatory requirements of OECD TG 414.
Why is the test carried out?
OECD TG 414 is being carried out for the following scientific and regulatory purposes:
- Assessment of developmental toxicity: identification of adverse effects of the test substance on embryonic and foetal development
- Assessment of teratogenic potential: identification of structural malformations and developmental abnormalities
- Evidence of a link to maternal toxicity: scientific interpretation as to whether the observed embryo-foetal effects are independent of maternal toxicity
- Support for regulatory documentation: use in the safety assessment of medicinal products, chemicals, pesticides, biocidal products, medical devices and biotechnological products
- Approach to weight of evidence: contribution to risk assessment in conjunction with other toxicity data, physicochemical properties and exposure assessment
- Product safety and quality assurance: Documentation of the biosafety profile of raw materials, intermediates or finished products
OECD Guideline TG 414 does not cover the entire reproductive toxicity profile. Fertility, early embryonic development and postnatal development are assessed in separate tests. The results should be interpreted in conjunction with the relevant regulatory guidelines and other data on reproductive toxicity.
As part of our nano-testing services, we carry out tests in accordance with OECD TG 414 with scientific rigour, drawing on our accredited laboratory facilities and our quality management system. Our scope of services includes the following:
Study design and protocol development
- Preparation of a test report in accordance with OECD TG 414
- Determination of the dosage range and definition of the main experimental design in accordance with the physicochemical properties of the test substance
- Determination of negative controls, solvent controls and, where appropriate, suitable positive control groups
- Scientific justification for the choice of species, route of administration, dosage levels and duration of administration
- Compliance with ethical approval and animal welfare requirements
For your studies under OECD TG 414, you can contact Nano-Test to obtain information on study design, species selection, sample acceptance criteria, the test schedule and reporting procedures. We will draw up a bespoke study plan for you, tailored to the physicochemical properties of the test substance and your regulatory objectives.

